How many studies have been conducted on Thrombospondin 1?

BiohacksAI has indexed 300 PubMed studies on Thrombospondin 1, including 1 randomized controlled trials (RCTs). 20% of studies involve human subjects.

What are the main research areas for Thrombospondin 1?

The primary research domains for Thrombospondin 1 are 🔬 Oncology, 🦴 Bone & Joint, ✨ Skin & Hair. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Thrombospondin 1

An extracellular matrix glycoprotein from platelets and a variety of normal and transformed cells of both mesenchymal and epithelial origin. Thrombospondin-1 is believed to play a role in cell migration and proliferation, during embryogenesis and wound repair. Also, it has been studied for its use as a potential regulator of tumor growth and metastasis.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 46.2

Research Domains

Thrombospondin 1 has been studied across 18 research domains including 🔬 Oncology, 🦴 Bone & Joint, ✨ Skin & Hair, 🛡️ Immunity, ❤️ Cardiovascular. The primary research focus is 🔬 Oncology with 29% of studies addressing this area.

Loading evidence profile...

This evidence profile for Thrombospondin 1 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.